Abstract
Purpose
There is increasing evidence that the ovarian extracellular matrix (ECM) plays a critical role in follicle development. The rigidity of the cortical ECM limits expansion of the follicle and consequently oocyte maturation, maintaining the follicle in its quiescent state. Quiescent primordial, primary, and secondary follicles still exist in primary ovarian insufficiency (POI) patients, and techniques as in vitro activation (IVA) and drug-free IVA have recently been developed aiming to activate these follicles based on the Hippo signaling disruption that is essential in mechanotransduction. In this context, we analyze the effect of drug-free IVA in POI patients, comparing the relationship between possible resumption ovarian function and biomechanical properties of ovarian tissue.
Methods
Nineteen POI patients according to ESHRE criteria who underwent drug-free IVA by laparoscopy between January 2018 and December 2019 and were followed up for a year after the intervention. A sample of ovarian cortex taken during the intervention was analyzed by atomic force microscopy (AFM) in order to quantitatively measure tissue stiffness (Young’s elastic modulus, E) at the micrometer scale. Functional outcomes after drug-free were analyzed.
Results
Resumption of ovarian function was observed in 10 patients (52.6%) and two of them became pregnant with live births. There were no differences in clinical characteristics (age and duration of amenorrhea) and basal hormone parameters (FSH and AMH) depending on whether or not there was activation after surgery. However, ovarian cortex stiffness was significantly greater in patients with ovarian activity after drug-free IVA: median E = 5519 Pa (2260–11,296) vs 1501 (999–3474); p-value < 0.001.
Conclusions
Biomechanical properties of ovarian cortex in POI patients have a great variability, and higher ovarian tissue stiffness entails a more favorable status when drug-free IVA is applied in their treatment. This status is probably related to an ovary with more residual follicles, which would explain a greater possibility of ovarian follicular reactivations after treatment.
Similar content being viewed by others
References
De Vos M, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet. 2010;376(9744):911–21. https://doi.org/10.1016/S0140-6736(10)60355-8.
European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI;, Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31:926–37.
Nelson LM. Clinical practice Primary ovarian insufficiency. N Engl J Med. 2009;360(6):606–14. https://doi.org/10.1056/NEJMcp0808697.
Hsueh AJ, Kawamura K, Cheng Y, Fauser BC. Intraovarian control of early folliculogenesis. Endocr Rev. 2015;36(1):1–24. https://doi.org/10.1210/er.2014-1020.
Ford EA, Beckett EL, Roman SD, McLaughlin EA, Sutherland JM. Advances in human primordial follicle activation and premature ovarian insufficiency. Reproduction. 2020;159(1):R15–29. https://doi.org/10.1530/REP-19-0201.
Kawamura K, Cheng Y, Suzuki N, et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci USA. 2013;110(43):17474–9. https://doi.org/10.1073/pnas.1312830110.
Suzuki N, Yoshioka N, Takae S, et al. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency. Hum Reprod. 2015;30(3):608–15. https://doi.org/10.1093/humrep/deu353.
Kawamura K, Kawamura N, Hsueh AJ. Activation of dormant follicles: a new treatment for premature ovarian failure? Curr Opin Obstet Gynecol. 2016;28(3):217–22. https://doi.org/10.1097/GCO.0000000000000268.
Fabregues F, Ferreri J, Calafell JM, et al. Pregnancy after drug-free in vitro activation of follicles and fresh tissue autotransplantation in primary ovarian insufficiency patient: a case report and literature review. J Ovarian Res. 2018;11(1):76. https://doi.org/10.1186/s13048-018-0447-3.
Ferreri J, Fàbregues F, Calafell JM, et al. Drug-free in-vitro activation of follicles and fresh tissue autotransplantation as a therapeutic option in patients with primary ovarian insufficiency. Reprod Biomed Online. 2020;40(2):254–60. https://doi.org/10.1016/j.rbmo.2019.11.009.
Kawamura K, Ishizuka B, Hsueh AJW. Drug-free in-vitro activation of follicles for infertility treatment in poor ovarian response patients with decreased ovarian reserve. Reprod Biomed Online. 2020;40(2):245–53. https://doi.org/10.1016/j.rbmo.2019.09.007.
Patel NH, Bhadarka HK, Patel NH, Patel MN. Drug-free in vitro activation for primary ovarian insufficiency. J Hum Reprod Sci. 2021;14(4):443–5. https://doi.org/10.4103/jhrs.jhrs_56_21.
Pan D. Hippo signaling in organ size control. Genes Dev. 2007;21(8):886–97. https://doi.org/10.1101/gad.1536007.
Fernández BG, Gaspar P, Brás-Pereira C, Jezowska B, Rebelo SR, Janody F. Actin-Capping Protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila. Development. 2011;138(11):2337–46. https://doi.org/10.1242/dev.063545.
Thorne JT, Segal TR, Chang S, Jorge S, Segars JH, Leppert PC. Dynamic reciprocity between cells and their microenvironment in reproduction. Biol Reprod. 2015;92(1):25. https://doi.org/10.1095/biolreprod.114.121368.
Shah JS, Sabouni R, Cayton Vaught KC, Owen CM, Albertini DF, Segars JH. Biomechanics and mechanical signaling in the ovary: a systematic review. J Assist Reprod Genet. 2018;35(7):1135–48. https://doi.org/10.1007/s10815-018-1180-y.
Woodruff TK, Shea LD. A new hypothesis regarding ovarian follicle development: ovarian rigidity as a regulator of selection and health. J Assist Reprod Genet. 2011;28(1):3–6. https://doi.org/10.1007/s10815-010-9478-4.
Ouni E, Bouzin C, Dolmans MM, et al. Spatiotemporal changes in mechanical matrisome components of the human ovary from prepuberty to menopause. Hum Reprod. 2020;35(6):1391–410. https://doi.org/10.1093/humrep/deaa100.
Gjönnaess H. Polycystic ovarian syndrome treated by ovarian electrocautery through the laparoscope. Fertil Steril. 1984;41(1):20–5. https://doi.org/10.1016/s0015-0282(16)47534-5.
Farquhar C, Brown J, Marjoribanks J. Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev. 2012;13(6):CD001122. https://doi.org/10.1002/14651858.CD001122.pub4. Update in: Cochrane Database Syst Rev. 2020 Feb 11;2:CD001122.
Johnson KL. Contact Mechanics. London: Cambridge University Press; 1985. https://doi.org/10.1017/CBO9781139171731.
Andreu I, Luque T, Sancho A, Pelacho B, Iglesias-García O, Melo E, Farré R, Prósper F, Elizalde MR, Navajas D. Heterogeneous micromechanical properties of the extracellular matrix in healthy and infarcted hearts. Acta Biomater. 2014;10(7):3235–42. https://doi.org/10.1016/j.actbio.2014.03.034.
Alcaraz J, Otero J, Jorba I, Navajas D. Bidirectional mechanobiology between cells and their local extracellular matrix probed by atomic force microscopy. Semin Cell Dev Biol. 2018;73:71–81. https://doi.org/10.1016/j.semcdb.2017.07.020.
Otero J, Navajas D, Alcaraz J. Characterization of the elastic properties of extracellular matrix models by atomic force microscopy. Methods Cell Biol. 2020;156:59–83. https://doi.org/10.1016/bs.mcb.2019.11.016.
World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–4.
Fàbregues F, Ferreri J, Méndez M, Calafell JM, Otero J, Farré R. In vitro follicular activation and stem cell therapy as a novel treatment strategies in diminished ovarian reserve and primary ovarian insufficiency. Front Endocrinol (Lausanne). 2021;24(11):617704. https://doi.org/10.3389/fendo.2020.617704.
Fabregues F, Calafell JM, Manau D, et al. Pregnancy after orthotopic ovarian tissue transplantation using N-hexyl-2-cyanoacrylate. J Endometr Pelvic Pain Disord. 2017;9(3):216–21. https://doi.org/10.5301/jeppd.5000288.
Nonaka PN, Campillo N, Uriarte JJ, Garreta E, Melo E, de Oliveira LV, Navajas D, Farré R. Effects of freezing/thawing on the mechanical properties of decellularized lungs. J Biomed Mater Res A. 2014;102(2):413–9. https://doi.org/10.1002/jbm.a.34708.
Maas K, Mirabal S, Penzias A, Sweetnam PM, Eggan KC, Sakkas D. Hippo signaling in the ovary and polycystic ovarian syndrome. J Assist Reprod Genet. 2018;35(10):1763–71. https://doi.org/10.1007/s10815-018-1235-0.
Grosbois J, Devos M, Demeestere I. Implications of nonphysiological ovarian primordial follicle activation for fertility preservation. Endocr Rev. 2020;41(6):bnaa020. https://doi.org/10.1210/endrev/bnaa020.
Lee HN, Chang EM. Primordial follicle activation as new treatment for primary ovarian insufficiency. Clin Exp Reprod Med. 2019;46(2):43–9. https://doi.org/10.5653/cerm.2019.46.2.43.
Hsueh AJW, Kawamura K. Hippo signaling disruption and ovarian follicle activation in infertile patients. Fertil Steril. 2020;114(3):458–64. https://doi.org/10.1016/j.fertnstert.2020.07.031.
Jorge S, Chang S, Barzilai JJ, Leppert P, Segars JH. Mechanical signaling in reproductive tissues: mechanisms and importance. Reprod Sci. 2014;21(9):1093–107. https://doi.org/10.1177/1933719114542023.
Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol. 2011;13(8):877–83. https://doi.org/10.1038/ncb2303.
Grosbois J, Demeestere I. Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation. Hum Reprod. 2018;33(9):1705–14. https://doi.org/10.1093/humrep/dey250.
De Roo C, Lierman S, Tilleman K. De Sutter P 2020 In-vitro fragmentation of ovarian tissue activates primordial follicles through the Hippo pathway. Hum Reprod Open. 2020;4:hoaa048. https://doi.org/10.1093/hropen/hoaa048.
De Roo C, Tilleman K, Vercruysse C, et al. Texture profile analysis reveals a stiffer ovarian cortex after testosterone therapy: a pilot study. J Assist Reprod Genet. 2019;36(9):1837–43. https://doi.org/10.1007/s10815-019-01513-x.
Ouni E, Peaucelle A, Haas KT, et al. A blueprint of the topology and mechanics of the human ovary for next-generation bioengineering and diagnosis. Nat Commun. 2021;12(1):5603. https://doi.org/10.1038/s41467-021-25934-4.
Jorba I, Beltrán G, Falcones B, et al. Nonlinear elasticity of the lung extracellular microenvironment is regulated by macroscale tissue strain. Acta Biomater. 2019;92:265–76. https://doi.org/10.1016/j.actbio.2019.05.023.
Farré N, Otero J, Falcones B, et al. intermittent hypoxia mimicking sleep apnea increases passive stiffness of myocardial extracellular matrix. A multiscale study. Front Physiol. 2018;9:1143. https://doi.org/10.3389/fphys.2018.01143.
Jorba I, Menal MJ, Torres M, et al. Ageing and chronic intermittent hypoxia mimicking sleep apnea do not modify local brain tissue stiffness in healthy mice. J Mech Behav Biomed Mater. 2017;71:106–13. https://doi.org/10.1016/j.jmbbm.2017.03.001.
Stanisavljevic J, Loubat-Casanovas J, Herrera M, et al. Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasis. Cancer Res. 2015;75(2):284–95. https://doi.org/10.1158/0008-5472.CAN-14-1903.
Wood CD, Vijayvergia M, Miller FH, et al. Multi-modal magnetic resonance elastography for noninvasive assessment of ovarian tissue rigidity in vivo. Acta Biomater. 2015;13:295–300. https://doi.org/10.1016/j.actbio.2014.11.022.
Funding
This study was supported in part by the grant “Premi Fi de Residencia Emili Letang 2017” from the Hospital Clinic of Barcelona: 398–37-250,777 PFR 2017.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Marta Méndez and Francesc Fabregues conceived, structured, and wrote the text. Material preparation and biomechanical analysis of tissue stiffness by AFM were performed by Alvaro Villarino, Jordi Otero, and Ramon Farre. Data collection and analysis were performed by Marta Méndez, Janisse Ferreri, and Josep Maria Calafell. Drug-free IVA by laparoscopy was performed by Francesc Fabregues, Janisse Ferreri, and Josep Maria Calafell. The study supervision was performed by Francesc Fabregues and Francisco Carmona. All authors commented on previous versions of the manuscript and approved the final version submitted.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
It was conducted according to the Declaration of Helsinki for Medical Research involving Human Subjects [20]. The study protocol was approved by Ethics Committee of the Hospital Clinic of Barcelona (registry number 2017/08569) in 2017. All patients provided written, informed consent to participate in the study.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Méndez, M., Fabregues, F., Ferreri, J. et al. Biomechanical characteristics of the ovarian cortex in POI patients and functional outcomes after drug-free IVA. J Assist Reprod Genet 39, 1759–1767 (2022). https://doi.org/10.1007/s10815-022-02579-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-022-02579-w